These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 36251124)

  • 1. The importance of assessing and addressing mental health barriers to PrEP use during pregnancy and postpartum in sub-Saharan Africa: state of the science and research priorities.
    Stanton AM; O'Cleirigh C; Knight L; Davey DLJ; Myer L; Joska JA; Mayer KH; Bekker LG; Psaros C
    J Int AIDS Soc; 2022 Oct; 25(10):e26026. PubMed ID: 36251124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers to Oral HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Pregnant and Post-partum Women from Cape Town, South Africa.
    Beesham I; Dovel K; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
    AIDS Behav; 2022 Sep; 26(9):3079-3087. PubMed ID: 35316471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
    Haribhai S; Khadka N; Mvududu R; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
    Int J STD AIDS; 2023 Jul; 34(8):548-556. PubMed ID: 36947792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stepped care to optimize pre-exposure prophylaxis (PrEP) effectiveness in pregnant and postpartum women (SCOPE-PP) in South Africa: a randomized control trial.
    Joseph Davey DL; Dovel K; Cleary S; Khadka N; Mashele N; Silliman M; Mvududu R; Nyemba DC; Coates TJ; Myer L
    BMC Public Health; 2022 Jul; 22(1):1306. PubMed ID: 35799121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-care testing for sexually transmitted infections and HIV pre-exposure prophylaxis among pregnant women in South Africa, 2021-2022: randomised controlled trial.
    de Voux A; Nyemba DC; Silliman M; Mashele N; Mvududu R; Myer L; Joseph Davey D
    Sex Transm Infect; 2024 Feb; 100(2):77-83. PubMed ID: 38124133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating a mental health intervention into PrEP services for South African young women: a human-centred implementation research approach to intervention development.
    Velloza J; Ndimande-Khoza N; Mills L; Concepcion T; Gumede S; Chauke H; Verhey R; Chibanda D; Hosek S; Weiner BJ; Celum C; Delany-Moretlwe S
    J Int AIDS Soc; 2024 Jul; 27 Suppl 1(Suppl 1):e26274. PubMed ID: 38965973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
    Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
    BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PrEP Implementation for Mothers in Antenatal Care (PrIMA): study protocol of a cluster randomised trial.
    Dettinger JC; Kinuthia J; Pintye J; Mwongeli N; Gómez L; Richardson BA; Barnabas R; Wagner AD; O'Malley G; Baeten JM; John-Stewart G
    BMJ Open; 2019 Mar; 9(3):e025122. PubMed ID: 30850409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early pre-exposure prophylaxis (PrEP) initiation and continuation among pregnant and postpartum women in antenatal care in Cape Town, South Africa.
    Joseph Davey DL; Mvududu R; Mashele N; Lesosky M; Khadka N; Bekker LG; Gorbach P; Coates TJ; Myer L
    J Int AIDS Soc; 2022 Feb; 25(2):e25866. PubMed ID: 35138678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenofovir Diphosphate Concentrations in Dried Blood Spots From Pregnant and Postpartum Adolescent and Young Women Receiving Daily Observed Pre-exposure Prophylaxis in Sub-Saharan Africa.
    Stranix-Chibanda L; Anderson PL; Kacanek D; Hosek S; Huang S; Nematadzira TG; Taulo F; Korutaro V; Nakabiito C; Masenya M; Lypen K; Brown E; Ibrahim ME; Yager J; Wiesner L; Johnston B; Amico KR; Rooney JF; Chakhtoura N; Spiegel HML; Chi BH;
    Clin Infect Dis; 2021 Oct; 73(7):e1893-e1900. PubMed ID: 33341883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Alcohol Use Is Associated With Increased Pre-exposure Prophylaxis (PrEP) Continuation and Adherence Among Pregnant and Postpartum Women in South Africa.
    Miller AP; Shoptaw S; Moucheraud C; Mvududu R; Essack Z; Gorbach PM; Myer L; Davey DLJ
    J Acquir Immune Defic Syndr; 2023 Mar; 92(3):204-211. PubMed ID: 36413977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation programme.
    Kinuthia J; Pintye J; Abuna F; Mugwanya KK; Lagat H; Onyango D; Begnel E; Dettinger J; Baeten JM; John-Stewart G;
    Lancet HIV; 2020 Jan; 7(1):e38-e48. PubMed ID: 31813837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rethinking HIV prevention to prepare for oral PrEP implementation for young African women.
    Celum CL; Delany-Moretlwe S; McConnell M; van Rooyen H; Bekker LG; Kurth A; Bukusi E; Desmond C; Morton J; Baeten JM
    J Int AIDS Soc; 2015; 18(4 Suppl 3):20227. PubMed ID: 26198350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa.
    Price JT; Wheeler SB; Stranix-Chibanda L; Hosek SG; Watts DH; Siberry GK; Spiegel HM; Stringer JS; Chi BH
    J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 2(Suppl 2):S145-53. PubMed ID: 27355502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "I had Made the Decision, and No One was Going to Stop Me" -Facilitators of PrEP Adherence During Pregnancy and Postpartum in Cape Town, South Africa.
    Joseph Davey DL; Knight L; Markt-Maloney J; Tsawe N; Gomba Y; Mashele N; Dovel K; Gorbach P; Bekker LG; Coates TJ; Myer L
    AIDS Behav; 2021 Dec; 25(12):3978-3986. PubMed ID: 34085132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PrEP implementation research in Africa: what is new?
    Cowan FM; Delany-Moretlwe S; Sanders EJ; Mugo NR; Guedou FA; Alary M; Behanzin L; Mugurungi O; Bekker LG
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21101. PubMed ID: 27760680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation, Retention and Adherence.
    Moran A; Mashele N; Mvududu R; Gorbach P; Bekker LG; Coates TJ; Myer L; Joseph Davey D
    AIDS Behav; 2022 Jan; 26(1):205-217. PubMed ID: 34287756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa.
    Hosek S; Celum C; Wilson CM; Kapogiannis B; Delany-Moretlwe S; Bekker LG
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21107. PubMed ID: 27760684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV pre-exposure prophylaxis initiation, persistence, and adherence during pregnancy through the postpartum period.
    Pintye J; Kinuthia J; Abuna F; Anderson PL; Dettinger JC; Gomez L; Haberer JE; Marwa MM; Ngumbau N; Omondi P; Odhiambo B; Stern J; Watoyi S; Baeten JM; John-Stewart G;
    AIDS; 2023 Sep; 37(11):1725-1737. PubMed ID: 37289583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.